Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1326187rdf:typepubmed:Citationlld:pubmed
pubmed-article:1326187lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:1326187lifeskim:mentionsumls-concept:C0007789lld:lifeskim
pubmed-article:1326187lifeskim:mentionsumls-concept:C0231335lld:lifeskim
pubmed-article:1326187lifeskim:mentionsumls-concept:C0443286lld:lifeskim
pubmed-article:1326187lifeskim:mentionsumls-concept:C0178602lld:lifeskim
pubmed-article:1326187lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:1326187pubmed:issue2lld:pubmed
pubmed-article:1326187pubmed:dateCreated1992-10-15lld:pubmed
pubmed-article:1326187pubmed:abstractTextAs many as 8 patients aged 8-19 years suffering from infantile cerebral paralysis (ICP) with torsion dystonia, akinetic, rigid, spastic and hypotonically atactic syndromes were examined for the maximum amplitude of EMG activity of the musculus tibialis anterior in voluntary rear flexion of the foot and in Strümpell's tibial synkinesia before treatment and after intake of small doses of L-DOPA (nakom, 62 mg/day). It has been established that the amplitude of voluntary EMG activity and the rate of impulse transmission in efferents of the tibial nerve remained practically unchanged during treatment; in all the cases, the synergic EMG activity, discharges of EMG and prolonged activity decreased; the scope of active movements in the talocrural joint increased by 10-20 degrees. The greatest decrease of synergic EMG activity (by 40%) was recorded in patients with rigid muscle tone, the mean in patients with spastic and spastic -dystonic (by 25-33%), the least one (17%) in muscle hypotonia. It is assumed that voluntary and synergic automatic movements have varying neuromediator supply. The effect of L-DOPA is realized via changes in the function of suprasegmental brain structures regulating polysynaptic postural reflexes with primary action on extensors. The effects of the subcortical nuclei, stem and cerebellar systems are made possible by dopamine neuromediation to a different measure.lld:pubmed
pubmed-article:1326187pubmed:languageruslld:pubmed
pubmed-article:1326187pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1326187pubmed:citationSubsetIMlld:pubmed
pubmed-article:1326187pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1326187pubmed:statusMEDLINElld:pubmed
pubmed-article:1326187pubmed:issn0044-4588lld:pubmed
pubmed-article:1326187pubmed:authorpubmed-author:Na?del'A VAVlld:pubmed
pubmed-article:1326187pubmed:authorpubmed-author:BakhteevK KKKlld:pubmed
pubmed-article:1326187pubmed:authorpubmed-author:BrinI LILlld:pubmed
pubmed-article:1326187pubmed:issnTypePrintlld:pubmed
pubmed-article:1326187pubmed:volume92lld:pubmed
pubmed-article:1326187pubmed:ownerNLMlld:pubmed
pubmed-article:1326187pubmed:authorsCompleteYlld:pubmed
pubmed-article:1326187pubmed:pagination86-8lld:pubmed
pubmed-article:1326187pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1326187pubmed:meshHeadingpubmed-meshheading:1326187-...lld:pubmed
pubmed-article:1326187pubmed:meshHeadingpubmed-meshheading:1326187-...lld:pubmed
pubmed-article:1326187pubmed:meshHeadingpubmed-meshheading:1326187-...lld:pubmed
pubmed-article:1326187pubmed:meshHeadingpubmed-meshheading:1326187-...lld:pubmed
pubmed-article:1326187pubmed:meshHeadingpubmed-meshheading:1326187-...lld:pubmed
pubmed-article:1326187pubmed:meshHeadingpubmed-meshheading:1326187-...lld:pubmed
pubmed-article:1326187pubmed:meshHeadingpubmed-meshheading:1326187-...lld:pubmed
pubmed-article:1326187pubmed:meshHeadingpubmed-meshheading:1326187-...lld:pubmed
pubmed-article:1326187pubmed:meshHeadingpubmed-meshheading:1326187-...lld:pubmed
pubmed-article:1326187pubmed:meshHeadingpubmed-meshheading:1326187-...lld:pubmed
pubmed-article:1326187pubmed:meshHeadingpubmed-meshheading:1326187-...lld:pubmed
pubmed-article:1326187pubmed:meshHeadingpubmed-meshheading:1326187-...lld:pubmed
pubmed-article:1326187pubmed:meshHeadingpubmed-meshheading:1326187-...lld:pubmed
pubmed-article:1326187pubmed:meshHeadingpubmed-meshheading:1326187-...lld:pubmed
pubmed-article:1326187pubmed:meshHeadingpubmed-meshheading:1326187-...lld:pubmed
pubmed-article:1326187pubmed:year1992lld:pubmed
pubmed-article:1326187pubmed:articleTitle[Effect of small doses of L-dopa on synergic tonic reaction in patients with childhood cerebral palsy].lld:pubmed
pubmed-article:1326187pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1326187pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:1326187pubmed:publicationTypeEnglish Abstractlld:pubmed